Welcome, Guest
Username: Password: Remember me
The Company
  • Page:
  • 1

TOPIC: Olympus Biotech- new distribution Agreement

Olympus Biotech- new distribution Agreement 29 Jan 2013 10:36 #72

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116
Olympus Biotech Announcement

For BonAlive Biomaterials for the UK, German and French markets- i.e. major part of the G5. BonAlive developed an osteoconductive matrix, which apparently also works well against chronic infections.
Obviously Olympus is still at it- i.e. making a presence in the orthopedic regenerative market and I still feel they need the "Living cell" in order to compete against the likes of Baxter, Medtronic, Stryker and Zimmer etc.
Doesnt have to be Cytori, but that would be most logical.

Time will tell. :dry:
The following user(s) said Thank You: Joncon63

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:
  • Page:
  • 1
Time to create page: 0.076 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.



Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites